Evaluation of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images
NCT ID: NCT04983953
Last Updated: 2022-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2021-06-23
2021-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The specific aims of this study are to evaluate efficacy of cHS for intracranial haemorrhage compared to the sensitivity and specificity levels of predicate device which is currently approved to triage intracranial haemorrhage.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients
NCT07100132
The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage
NCT06535438
Clinical Diagnosis and Treatment of Intracerebral Hemorrhage Based on Artificial Intelligence
NCT04951570
An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device
NCT02773888
Assessment of Intracerebral Hematoma
NCT05158660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abnormal
A patient diagnosed with intracranial haemorrhage after a brain CT scan
cHS
Clinical decision support system for diagnosing intracranial haemorrhage
Normal
A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan
cHS
Clinical decision support system for diagnosing intracranial haemorrhage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cHS
Clinical decision support system for diagnosing intracranial haemorrhage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Brain CT acquired
* Abnormal cohort: A patient diagnosed with intracranial haemorrhage after a brain CT scan
* Normal cohort: A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan
Exclusion Criteria
* Patients with brain abscess or brain calcification
* Poor or incomplete brain CT image quality
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heuron Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gachon University Gil Medical Center
Incheon, Namdong-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HR-cHS-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.